Dr. Joseph C. Wu, MD, PhD, is a Co-Founder of Greenstone Biosciences and a distinguished scientist specializing in cardiology. As the Director of the Stanford Cardiovascular Institute and the Simon H. Stertzer, MD, Professor of Medicine and Radiology, he has established himself as a leading figure in the field. Dr. Wu obtained his MD. from Yale University and a PhD. in molecular pharmacology from UCLA, laying the foundation for his extensive contributions to the application of induced pluripotent stem cells (iPSCs) in disease modeling, drug discovery, and regenerative medicine. With over 500 peer-reviewed articles and an impressive H-index of 123, Dr. Wu’s expertise is widely recognized, placing him among the top 0.1% highly cited researchers globally for the past five years. His exceptional achievements have garnered prestigious awards from the NIH and AHA, while his memberships in the NAI and NAM underscore his influential role in the scientific community.

Dr. Wu’s remarkable career spans both academia and industry, with his co-founding role at Greenstone Biosciences exemplifying his commitment to translating scientific discoveries into tangible solutions. His groundbreaking research on iPSCs and their potential applications in regenerative medicine and drug development has paved the way for innovative approaches to tackle cardiovascular diseases.

With his vast publication record and exceptional H-index, Dr. Wu’s contributions have made a lasting impact on the scientific community. His studies have shed light on the mechanisms of disease, provided valuable insights for developing targeted therapies, and accelerated progress in personalized medicine.

Beyond his research accolades, Dr. Wu’s membership in prestigious institutions such

as the National Academy of Inventors (NAI) and the National Academy of Medicine (NAM) reflects his influential role in shaping the future of healthcare and biomedical innovation.

As the incoming President of the American Heart Association, Dr. Wu is poised to lead the organization in its mission to combat heart disease and stroke, two leading causes of global mortality. His visionary leadership and expertise will undoubtedly contribute to advancing research, fostering collaborations, and advocating for policies that promote cardiovascular health.

Dr. Joseph C. Wu’s groundbreaking research, entrepreneurial spirit, and leadership positions highlight his dedication to improving patient care and driving scientific progress. His work continues to pave the way for novel therapies, offering hope to individuals affected by cardiovascular diseases worldwide.